AMENDMENT NO. 2 TO THE CONSULTING AGREEMENT BETWEEN MIRATI THERAPEUTICS, INC, and LAURIE STELZERConsulting Agreement • November 6th, 2023 • Mirati Therapeutics, Inc. • Pharmaceutical preparations
This Amendment No. 2 (the “Amendment”) is effective as of September 22, 2023 (the “Second Amendment Date”) by and between MIRATI THERAPEUTICS, INC. (“Mirati”) and LAURIE STELZER (“Consultant”). Mirati and Consultant are hereinafter collectively referred to as “Parties.”
August 7, 2023 David Meek Re: Separation Agreement Dear David:Separation Agreement • November 6th, 2023 • Mirati Therapeutics, Inc. • Pharmaceutical preparations
This letter sets forth the substance of the separation agreement (the “Agreement”) that Mirati Therapeutics, Inc. (the “Company”) is offering to you to aid in your employment transition.
AMENDMENT NO. 1 TO THE CONSULTING AGREEMENT BETWEEN MIRATI THERAPEUTICS, INC, and LAURIE STELZERConsulting Agreement • November 6th, 2023 • Mirati Therapeutics, Inc. • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”) is effective as of September 12, 2023 (the “Amendment Date”) by and between Mirati Therapeutics, Inc. (“Mirati”) and Laurie Stelzer (“Consultant”). Mirati and Consultant are hereinafter individually referred to as “Party” and collectively referred to as “Parties.”
CONSULTING AGREEMENTConsulting Agreement • November 6th, 2023 • Mirati Therapeutics, Inc. • Pharmaceutical preparations • California
THIS CONSULTING AGREEMENT (the “Agreement”) is effective on September 9, 2023 (the “Effective Date”) by and between MIRATI THERAPEUTICS, INC., a Delaware corporation with principal offices at 3545 Cray Court, San Diego, CA 92121 (the “Company”) and LAURIE STELZER, an individual residing at 6125 N. 31st Ct., Phoenix, AZ 85016 (“Consultant”). Company and Consultant may be referred to herein individually as a “Party” and collectively as the “Parties”.
